These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36376856)

  • 1. Participatory disease surveillance for a mass gathering - a prospective cohort study on COVID-19, Germany 2021.
    Hohmuth N; Khanyaree I; Lang AL; Duering O; Konigorski S; Višković V; Heising T; Egender F; Remschmidt C; Leistner R
    BMC Public Health; 2022 Nov; 22(1):2074. PubMed ID: 36376856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between two mass-gathering outdoor events and incidence of SARS-CoV-2 infections during the fifth wave of COVID-19 in north-east Spain: A population-based control-matched analysis.
    Suñer C; Coma E; Ouchi D; Hermosilla E; Baro B; Rodríguez-Arias MÀ; Puig J; Clotet B; Medina M; Mitjà O
    Lancet Reg Health Eur; 2022 Apr; 15():100337. PubMed ID: 35237763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Prospective Seroconversion and PCR Data of Selected Cohorts Indicate a High Rate of Subclinical SARS-CoV-2 Infections-an Open Observational Study in Lower Saxony, Germany.
    Jonczyk R; Stanislawski N; Seiler LK; Blume H; Heiden S; Lucas H; Sarikouch S; Pott PC; Stiesch M; Hauß C; Saletti G; González-Hernández M; Kaiser FK; Rimmelzwaan G; Osterhaus A; Blume C
    Microbiol Spectr; 2022 Feb; 10(1):e0151221. PubMed ID: 35171028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Spatiotemporal Clusters of COVID-19-Associated Symptoms and Prevention Using a Participatory Surveillance App: Protocol for the @choum Study.
    De Ridder D; Loizeau AJ; Sandoval JL; Ehrler F; Perrier M; Ritch A; Violot G; Santolini M; Greshake Tzovaras B; Stringhini S; Kaiser L; Pradeau JF; Joost S; Guessous I
    JMIR Res Protoc; 2021 Oct; 10(10):e30444. PubMed ID: 34449403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conducting mass gathering events during the COVID-19 pandemic: a case study of Kumbh Mela 2021 as a potential 'super spreader event'.
    Shukla S; Khan R; Ahmed Y; Memish ZA
    J Travel Med; 2021 Dec; 28(8):. PubMed ID: 34609481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Authors' response: Occupation and SARS-CoV-2 infection risk among workers during the first pandemic wave in Germany: potential for bias.
    Reuter M; Rigó M; Formazin M; Liebers F; Latza U; Castell S; Jöckel KH; Greiser KH; Michels KB; Krause G; Albrecht S; Öztürk I; Kuss O; Berger K; Lampl BMJ; Leitzmann M; Zeeb H; Starke KR; Schipf S; Meinke-Franze C; Ahrens W; Seidler A; Klee B; Pischon T; Andreas Deckert AD; Schmidt B; Mikolajczyk R; Karch A; Bohn B; Brenner H; Holleczek B; Dragano N
    Scand J Work Environ Health; 2022 Sep; 48(7):588-590. PubMed ID: 36153787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syndromic Surveillance Insights from a Symptom Assessment App Before and During COVID-19 Measures in Germany and the United Kingdom: Results From Repeated Cross-Sectional Analyses.
    Mehl A; Bergey F; Cawley C; Gilsdorf A
    JMIR Mhealth Uhealth; 2020 Oct; 8(10):e21364. PubMed ID: 32997640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of the Cologne Corona surveillance (CoCoS) study - a prospective population-based cohort study: incidence data and potential underestimation of new SARS-CoV-2 adult infections by health authorities.
    Oberste M; Pusch LM; Roth R; Shah-Hosseini K; Schmitz J; Heger E; Dewald F; Müller C; von Goltzheim LS; Lehmann C; Buess M; Wolff A; Fätkenheuer G; Wiesmüller G; Klein F; Rosenberger KD; Neuhann F; Hellmich M
    BMC Public Health; 2022 Jul; 22(1):1379. PubMed ID: 35854283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participatory Surveillance for COVID-19 Trend Detection in Brazil: Cross-sectional Study.
    Wittwer S; Paolotti D; Lichand G; Leal Neto O
    JMIR Public Health Surveill; 2023 Apr; 9():e44517. PubMed ID: 36888908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study.
    Sudre CH; Keshet A; Graham MS; Joshi AD; Shilo S; Rossman H; Murray B; Molteni E; Klaser K; Canas LD; Antonelli M; Nguyen LH; Drew DA; Modat M; Pujol JC; Ganesh S; Wolf J; Meir T; Chan AT; Steves CJ; Spector TD; Brownstein JS; Segal E; Ourselin S; Astley CM
    Lancet Digit Health; 2021 Sep; 3(9):e577-e586. PubMed ID: 34305035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Self-Assessment Web-Based App to Assess Trends of the COVID-19 Pandemic in France: Observational Study.
    Denis F; Fontanet A; Le Douarin YM; Le Goff F; Jeanneau S; Lescure FX
    J Med Internet Res; 2021 Mar; 23(3):e26182. PubMed ID: 33709945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol of the Luebeck longitudinal investigation of SARS-CoV-2 infection (ELISA) study - a prospective population-based cohort study.
    Balck A; Föh B; Borsche M; Rahmöller J; Vollstedt EJ; Waldeck F; Käding N; Twesten C; Mischnik A; Gillessen-Kaesbach G; Ehlers M; Sina C; Taube S; Busch H; Rupp J; Katalinic A; Klein C
    BMC Public Health; 2022 Jul; 22(1):1305. PubMed ID: 35799167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participatory syndromic surveillance as a tool for tracking COVID-19 in Bangladesh.
    Mahmud AS; Chowdhury S; Sojib KH; Chowdhury A; Quader MT; Paul S; Saidy MS; Uddin R; Engø-Monsen K; Buckee CO
    Epidemics; 2021 Jun; 35():100462. PubMed ID: 33887643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-household social gatherings contribute to the second SARS-CoV-2 wave in Rhineland-Palatinate, Germany, August to November 2020.
    Schepers M; Zanger P; Jahn K; König J; Strauch K; Gianicolo E
    J Infect; 2022 Apr; 84(4):551-557. PubMed ID: 35081437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of SARS-CoV-2 Surveillance Testing Among Children and Childcare Workers at German Day Care Centers: A Nonrandomized Controlled Trial.
    Forster J; Streng A; Rudolph P; Rücker V; Wallstabe J; Timme S; Pietsch F; Hartmann K; Krauthausen M; Schmidt J; Ludwig T; Gierszewski D; Jans T; Engels G; Weißbrich B; Romanos M; Dölken L; Heuschmann P; Härtel C; Gágyor I; Figge MT; Kurzai O; Liese J;
    JAMA Netw Open; 2022 Jan; 5(1):e2142057. PubMed ID: 34982157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass gathering events and the spread of infectious diseases: Evidence from the early growth phase of COVID-19.
    González-Val R; Marcén M
    Econ Hum Biol; 2022 Aug; 46():101140. PubMed ID: 35525103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.